Acutaas Chemicals Limited, formerly Ami Organics Limited, is a manufacturer of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.As of 9 Jun 2026, Ami Organics share price is ₹3,223.40. The stock opened at ₹3,300.00, compared to its previous close of ₹3,316.20. During today's trading session, Ami Organics share price moved in the range of ₹3,204.90 to ₹3,311.60, with an average price of ₹3,258.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,204.90 and a high of ₹3,311.60. On the performance front, Ami Organics share price has increased by 100.86% over the last six months and is up 190.77% on a year-on-year basis.
The market capitalization of Ami Organics is ₹27,250 Crs, with a P/E ratio of 76.1 and a dividend yield of 0.08%.